Hepatitis C-associated osteosclerosis (HCAO) is an uncommon condition characterized by increased bone density, skeletal pain and elevated bone formation markers. Since 1992, only 17 cases have been reported. We herein describe the case of a 61-year-old woman affected by severe pain involving the lower limbs. The laboratory data showed an elevated serum alkaline phosphatase level, and the patient was found to be seropositive for hepatitis C virus infection. In addition, an X-ray skeleton survey showed marked cortical thickening of both femurs and tibias, and a whole-body bone scan revealed an increased cortical radionuclide uptake in the involved bones. These findings were consistent with a diagnosis of HCAO. In this report, we discuss the patient's clinical course over 16 years and, for the first time, show a normalized radioisotope uptake on bone scanning 10 years after the diagnosis.
Introduction
Generalized osteosclerosis is characterized by the diffuse elevation of bone density and occurs in a variety of disorders, such as osteopetrosis, osteopoikilosis, chronic idiopathic myelofibrosis and other diseases (Table 1) . In most cases, the condition is associated with an inherited disease; however, acquired osteosclerosis has been described in patients with hematologic malignancies (1) or excessive fluoride exposure (2) .
Hepatitis C-associated osteosclerosis (HCAO) is an uncommon acquired condition characterized by increased bone density, skeletal pain and elevated bone formation markers in adults infected with the hepatitis C virus (HCV). Since 1992, 17 cases of HCAO have been reported, with ages ranging from 27-74 years and most patients having a history of IV drug abuse (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . In cases in which skeletal biopsies have been performed, the authors have described increased rates of bone accretion with findings of dense lamellar osseous tissue. Only a very small percentage of all patients infected with HCV develop osteosclerosis, and the natural history of this complication has not been clearly elucidated. Nevertheless, clinicians should be aware of this condition. This report describes the case of an elderly woman with HCAO whose clinical course was followed for a period of 16 years.
Case Report
A 61-year-old woman was referred to our hospital for the treatment of severe pain involving her lower limbs, from the thighs to the extremities, with resistance to therapy with common analgesics. The patient's discomfort had increased progressively over the previous year and was constant and not related to activity. Although she was in good health, two years earlier, she had received a diagnosis of osteoporosis. At that time, in 1996, a routine computerized bone densitometry scan showed a reduced bone mass density (BMD) at the femoral (0.754 g/cm 2 ) and lumbar (0.723 g/cm 2 ) levels; however, she refused any treatment. The patient had no history of bone fractures and had a negative family history for skeletal disease. She had worked as a shop assistant, was not a smoker and had no history of alcohol intake. A physi- cal examination was unremarkable, except for tenderness upon moderate pressure applied over the femurs and tibias; there were no skeletal deformities. Primary serum assays showed values above the normal ranges for transaminases, bone-specific alkaline phosphatase (ALP), osteocalcin and parathyroid hormone, whereas the serum calcium level was normal (Table 2) . Meanwhile, abdominal computerized tomography (CT) revealed hepatic steatosis, although no other abnormalities were found. The patient was subsequently found to be seropositive for hepatitis C antibodies on an enzyme-linked immunosorbent assay (ELISA). She had no history of blood transfusions, intravenous drug abuse, tattoos or acupuncture. A serum hepa- titis C RNA polymerase chain reaction assay was positive (genotype 2a/2c; 4.78 log copies/mL); however, serologic studies for HBsAg, HBsAb and HBcAb were negative.
Skeletal radiographs and bone scans were performed, and an X-ray skeleton survey showed marked cortical thickening of both femurs and tibias, without evidence of focal sclerosis or narrowing of the medullary canal (Fig. 1A) . A wholebody Technetium-99m bone scan revealed an increased cortical radionuclide uptake in the involved bones, with the diaphysis being predominantly affected, a finding consistent with a marked periosteal osteoblastic activity (Fig. 1B) . In addition, bone densitometry showed an enhanced rate of bone formation, with an increase in the bone mass of the femur of 46% (Fig. 2) . A transiliac crest biopsy was refused by the patient.
In making the differential diagnosis in this case, we considered the possibility of bone marrow disorders (neoplastic, granulomatous and hematological), heavy metal poisoning, fluoride excess, renal osteodystrophy, hyperhypoparathyroidism, Engelmann disease (progressive diaphyseal dysplasia) and Ribbing disease (multiple diaphyseal sclerosis). Most cases of sclerosing bone dysplasia are heritable; however, our patient's family history was negative for this condition. In addition, the above disorders were excluded based on the findings of appropriate investigations, and a physical examination showed no evidence of neoplastic, granulomatous or hematological disorders associated with osteosclerosis. Primary hyperparathyroidism may cause osteosclerosis (19) , and our patient's serum parathyroid hormone (PTH) level was elevated, but only in the presence of a repeatedly normal calcium level. Furthermore, a full blood count, measurements of the serum creatinine, fluoride and vitamin A levels and urinary heavy metal screening tests were normal, and the patient's normal serum 25-hydroxy vitamin D level excluded a diagnosis of excess vitamin D ingestion. Finally, thyroid function studies showed autoimmune hypothyroidism.
Based on the patient's clinical presentation, laboratory data and imaging findings, a diagnosis of hepatitis Cassociated osteosclerosis was made. She subsequently received treatment with alendronate at a dose of 10 mg daily, and, over the ensuing seven months, biochemical studies showed a reduction in the serum ALP activity from 677 to 90 U/L (Fig. 2) . The hip bone density also decreased from 1.140 to 1.060 g/cm 2 within one year. These changes were accompanied by the progressive resolution of the patient's lower extremity pain. No antiviral therapy was started in this case because such treatment was refused by the patient. Four years later, she developed type 2 diabetes mellitus. The follow-up period in the current case was 16 years. In that period, nine years after her referral to our department, the patient experienced an ischemic stroke with the abrupt onset of left hemiplegia, and CT scanning confirmed the presence of an ischemic lesion in the area of internal carotid vascularization. She was subsequently treated with antiplatelets agents, and her symptoms were progressively ameliorated. More than 10 years after the diagnosis of HCAO, she sustained a traumatic wrist fracture, D11 vertebral fracture and pertrochanteric fracture of the left femur, all after various falls. The femoral fracture was surgically treated with closed reduction and intramedullary nail fixation. At that time, an X-ray showed persistent marked cortical thickening of both femurs (Fig. 1C) and bone densitometry confirmed further increases in the bone mass (Fig. 2) , whereas, two years earlier, a bone scan had demonstrated complete regression of the cortical radionuclide uptake (Fig. 3) .
Discussion
Despite the high prevalence of HCV among the general population, HCAO is a very uncommon condition, characterized by a general increase in bone mass in infected patients. This condition was initially described in two intravenous drug abusers who were also seropositive for hepatitis C (4); since 1992, 17 cases of HCAO have been reported (4-18) in patients who acquired hepatitis C from blood transfusions and even possibly acupuncture, rather than intravenous drug abusers (Table 3 ). Similar to that observed in other reported cases, our patient reported no history of intravenous drug abuse, although she did have hepatitis C infection, likely acquired via a blood transfusion. HCAO has been reported in 10 cases in the United States, three cases in Japan, one case in Australia, two cases in Italy and one case in France, with patient ages ranging from 27 to 74 years. HCAO manifests as deep bone pain and tenderness over the involved bones due to periosteal stretching and bone marrow edema, in the absence of joint swelling or motion limitations. There might be a long latency period, up to 43 years, between HCV infection and the development of skeletal abnormalities (14) . In our patient, we cannot say how many years the symptoms began after the acquisition of the virus. There are currently no reports of affected patients with bone deformities or fractures.
The most common laboratory test abnormality is the elevation of markers of bone formation, including ALP, bonespecific ALP and osteocalcin. Generally, the serum calcium and phosphorous levels are normal, whereas the urinary calcium excretion is decreased. The serum PTH and 1,25-dihydroxyvitamin D levels are increased or normal, presumably due to mild secondary hyperparathyroidism, possibly as moderate increase in RANKL-positive stromal cells and a severe reduction in osteoclasts (13) . These findings are consistent with the pathogenetic role of OPG/RANKL system imbalances in cases of HCAO. If our patient had been successfully treated with antiviral agents, such as interferon (IFN), thus eradicating the HCV, the direct link between HCV and bone disease should have been more apparent.
Regarding therapeutic approaches for osteosclerosis, treatment with calcium and drugs that inhibit the osteoclast function may decrease the serum ALP activity, with variability in the response. In most cases, symptomatic treatment provides some benefit, and, in some cases, the partial or complete spontaneous remission of symptoms and bone sclerosis was observed during follow-up (4, 9) . In one case report, the administration of antiviral therapy was followed by a recovery in skeletal sclerosis; that case provides the first clinical evidence of a relationship between viral infection and osteoblast stimulation in humans (16) . The natural history of HCAO is unclear, with some authors reporting the spontaneous gradual remission of bone pain and normalization of biochemical parameters over several years and others describing the persistence of symptoms for 15 years with no signs of remission (15) . In most cases, there was no followup of the skeletal lesions, although longitudinal data were obtained for three years in one case (14) and 16 years in another case (16) .
To the best of our knowledge, we herein reported, for the first time, the complete regression of cortical radionuclide uptake, as assessed on bone scans, 10 years after the diagnosis of HCAO (Fig. 3) . However, despite the regression of the metabolic bone activity, the patient exhibited persistent cortical thickening on X-ray images and an increased bone mass density on bone densitometry (Fig. 2) . Moreover, she subsequently developed multiple fractures after several falls, suggesting that an impaired bone quality, not merely bone quantity (bone mineral density), contributes to the reduced bone strength observed in patients with this condition.
HCV infection is responsible for a great number of hepatic and extrahepatic disorders (20) . Osteosclerosis is a very uncommon condition in adults infected with HCV and is characterized by the presence of skeletal pain with an increased bone mass. Despite the low incidence of HCAO, clinicians should be aware of this disease, the pathogenesis of which remains unknown, although, in some cases, the partial or complete spontaneous remission of symptoms and bone sclerosis has been observed. In the current case, the spontaneous progressive regression of the metabolic bone activity associated with the onset of persistent bone sclerosis and increased bone fragility was documented over a long-term follow-up period.
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